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 ABSTRACT 
OBJECTIVE: The objective of this selective EBM review is to determine whether or not pre-
hospital therapeutic hypothermia improves the functional and survival status of post cardiac 
arrest patients.  
 
STUDY DESIGN: Review of three English language primary studies, two of which were 
published in 2007 and one in 2010. 
 
DATA SOURCES: Two randomized, controlled, clinical trials and one cohort study comparing 
pre-hospital therapeutic hypothermia to induction of therapeutic hypothermia upon hospital 
admission, and to standard normothermic post cardiac arrest care. All were found using Medline, 
OVID, and Cochrane Systematic databases. 
 
OUTCOMES MEASURED: An outcome measured was functional status at hospital discharge, 
defined by cognitive function and neurophysical outcomes. Survival status was also evaluated 
and based on whether patients became conscious, were discharged from the hospital alive, or 
whether they expired.   
 
RESULTS: Kim and Tiainen et al demonstrated that therapeutic hypothermia may improve 
survival status and improve functional status respectively for patients with an initial rhythm of 
ventricular fibrillation when compared to patients who received standard normothermic post 
cardiac arrest care. Both studies, however, failed to show conclusive statistical significance 
supporting the benefits of therapeutic hypothermia. Bernard et al reported improved functional 
outcomes in patients who received cooling upon hospital admission compared to pre-hospital 
cooling, but similarly, results were not statistically significant. All methods used were 
determined to be feasible for out-of-hospital use and to decrease core body temperature.  
Additionally, methods were not associated with adverse outcomes such as cognitive decline or 
pulmonary edema.  
 
CONCLUSIONS: The results of the three clinical trials show that there is inconclusive evidence 
that pre-hospital therapeutic hypothermia improves the functional and survival status of patients 
following cardiac arrest. Two of the three trials report an increased occurrence of favorable 
outcomes for patients treated with pre-hospital therapeutic hypothermia.  This data supports that 
further studies with adequate sample sizes, improved compliance, and more rapid and adequate 
induction of cooling should be considered to determine if this treatment could significantly 
improve patient outcomes. 
 
KEY WORDS: Cardiopulmonary resuscitation, Cardiac arrest, Therapeutic hypothermic
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INTRODUCTION 
Cardiovascular disease is the leading cause of morbidity and
mortality worldwide, with as many as 17 million deaths per year, the majority attributed to 
sudden cardiac arrest.3 Annually, 36-128/100,000 people in industrialized countries experience 
out-of hospital cardiac arrest (OHCA), and 50-80% of these arrests progress to ventricular 
fibrillation (VF) and result in death.3 More effective methods to treat CA remain under research, 
because current methods including rapid defibrillation and advanced cardiac life support (ACLS) 
resuscitate less than 50% of patients successfully.1 Of those patients who are resuscitated, many 
experience severe anoxic neurologic injury.  Anoxic injury often clinically manifests as a coma, 
a state that 80% of patients remain in for longer than one hour and may lead to subsequent in-
hospital death.1,3 Full cerebral recovery of admitted patients after this event is rare, and good 
cerebral recovery is achieved in 11-48% of resuscitated patients.3 Therapeutic hypothermia may 
offer neurologic protection by reducing cell death, protecting lipid membrane fluidity, reducing 
intracellular acidosis and destruction caused by enzymatic processes, as well as temporarily 
reducing oxygen requirements.3 If this is accomplished without compromising microvascular 
blood flow, therapeutic hypothermia may protect CNS neurons and improve patient functional 
and survival status. 
 As the leading cause of death in America, cardiovascular disease claims over 150,000 
people under the age of 65 annually, and contributes to 4 million disability claims.2 Physician 
assistants are involved in resuscitation attempts of patients in CA, as well as their immediate and 
long-term care following a successful resuscitation. Annual health care visits to treat heart 
disease and manage patients after an acute event include 65.8 million primary care visits, 6.8 
million outpatient hospital visits, and 4.4 million emergency department visits.2 It is estimated 
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that $444 billion was spent to manage the morbidity and mortality of cardiovascular diseases in 
2010.2 Improved functional status following CA will reduce the number of patients who claim 
disability and the dollars spent on long-term post-CA care.   
Most victims of cardiac arrest have pathologic CAD, chronic atherosclerosis, diabetes, 
hyperlipdemia, hypertension and a history of smoking. Cardiac arrest may happen independently 
of, or progress from, myocardial infarction. During this event, the myocardium ceases to 
contract, arresting blood circulation and oxygen delivery most notably to the brain. Prolonged 
CNS oxygen deprivation leads to respiratory arrest and decreases chances of neurologic 
recovery. Cardiovascular and neurological damage may occur during and or after an arrest.3 
Following the return of circulation, re-oxygenation can initiate chemical cascades that further 
contribute to necrosis and apoptosis of neural and cardiac cells. Sources of damage include 
perfusion failure, re-oxygenation injury, post anoxic viscera, and blood stasis during cardiac 
arrest.3  
Currently, BLS and ACLS are the standard of care for cardiac arrest. This involves CPR, 
defibrillation when a shockable rhythm is present, and vasoactive and antiarrhythmics drugs 
including epinephrine, atropine, and amiodarone.3 Post resuscitation care and long-term 
management includes ICD placement and cardiac catheterization with stent placement. These 
treatment options have increased favorable outcomes and survival rates following cardiac arrest; 
however, close to 50% of surviving patients have moderately impaired neurologic function3.   
Therapeutic hypothermia following an ischemic event aims to reduce cell death and 
decrease reactive oxygen species and post-ischemic inflammation. Creating a neurologically 
protective state, this may improve patient functional and survival status.  This selective evidence 
based medicine review was done to determine if there is an improvement in patient functional 
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and survival status when implementing pre-hospital therapeutic hypothermia following cardiac 
arrest.  
OBJECTIVE 
The objective of this selective EBM review is to determine whether or not pre-hospital 
therapeutic hypothermia improves the functional and survival status of post cardiac arrest 
patients.  
METHODS 
 The studies selected for this evidence based medicine review included patients > 15 years 
old, assessed by paramedics for OHCA of presumed cardiac origin, with initial rhythm of VF.  
All patients had IV access available.  Each study included an intervention where pre-hospital 
therapeutic hypothermia was induced via IV solution < 8 ºC or an external cooling device.   
Patients were maintained in a hypothermic state for 24 hours using an external cooling device 
with a target core body temperature of 33 ºC.  Variations existed between studies.  Pre-hospital 
therapeutic hypothermia was compared to standard normothermic post cardiac arrest care 
followed by infusion of ice-cold LR upon hospital arrival in one single blind randomized 
controlled trial (RTC) or to standard normothermic pre-hospital CA therapy with maintained 
normothermia upon admission in another single blind RTC and a cohort study.  Outcomes 
evaluated in these studies include functional status at hospital discharge and survival status. 
Data was researched using Medline, OVID, and Cochrane databases and was located using 
the key words “Cardiopulmonary resuscitation”, “Cardiac arrest”, and “Therapeutic 
hypothermia”.  All articles were published in English from 2007-2010 in peer-reviewed journals 
and were selected based on their relevance and importance of outcomes to patients.  Inclusion 
criteria were defined by studies that were randomized controlled trials with OHCA patients.  
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Studies included POEMS and were published after 1996. Patients 15 years old or younger, 
involved in traumatic CA, pregnant, or responded to verbal command following ROSC were 
excluded. Statistics used to evaluate patient outcomes included: p-value, RBI, ABI, and NNT.  
Table 1: Demographics & Characteristics of included studies 
Study Type Pt # Age  Inclusion Criteria Exclusion Criteria W/D Intervention 
Bernar
d, 
2010 
(1) 
RCT, 
(blind, 
induction 
of 
therapeut
ic 
hypother
mia 
during 
hospital 
transport) 
234 >15 -Patients assessed by 
paramedics for OHCA 
with initial rhythm of 
VF  
-Patients return to 
spontaneous circulation 
with SBP >90mmHg 
-Cardiac arrest time >10 
minutes 
-Age >15 
-IV access available 
-Patients not 
intubated 
-Patients 
dependent on 
others for ADL’s 
prior to the cardiac 
arrest 
-Prior 
hypothermia 
(<34ºC) 
-Pregnant women 
0 -Standard 
pre-hospital 
therapy        
-Rapid 
infusion of 
40 mL/kg 
ice-cold 
lactated 
Ringer’s on 
hospital 
arrival 
Kim, 
2007 
(4) 
Pilot 
RCT 
(blind, 
standardi
zed care 
controlle
d) 
125 !18 - !18 years old 
-Patients resuscitated by 
paramedics from non-
traumatic OHCA  
-Patient with esophageal 
temperature ! 34°C 
-Patients had established 
IV access and were 
unconscious 
-VF, PEA, and asystole 
rhythms were accepted 
-Traumatic cardiac 
arrest 
- <18 years old 
-Patient able to 
follow commands 
-Temperature 
<34°C 
 
0 -Induction 
of mild 
hypothermia 
with rapid 
infusion of 
2L of 4°C 
normal 
saline 
immediately 
following 
resuscitation 
Tiaine
n, 
2007 
(6) 
Cohort 
study 
 
70 18-
75 
-Age 18-75 
-Witnessed cardiac 
arrest with VF or non-
perfusing tachycardia as 
the initial rhythm 
-Presumed cardiac origin 
of the arrest 
-Estimated interval of 5 
to 15 minutes from 
patient collapse to first 
resuscitation attempt 
- < 60 minutes from 
collapse to ROSC 
-Patients 
responding to 
verbal command 
following ROSC 
 
2 -Therapeutic 
hypothermia 
with a core 
temperature 
of 33±1°C 
achieved 
with an 
external 
cooling 
device; 
hypothermia 
maintained 
for 24 hours  
 
OUTCOMES MEASURED 
 All outcomes measured were POEMS related to functional and survival status of the 
patient.  Bernard et al accounted for patient functional status at hospital discharge.  Favorable 
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outcomes were defined as discharge to home or to a rehabilitation facility, and unfavorable 
outcomes were defined as patients who died or who were discharged to a long-term nursing 
facility, either conscious or unconscious.  A rehabilitation physician blinded to the trials 
allocation significance determined patient functional status and discharge direction.  Kim et al 
evaluated patient survival status by determining the number of deaths before hospital admission, 
the number of in-hospital deaths, and the number of patients discharged alive.  Data was 
collected from paramedic reports and hospital records.  
Tiainen et al evaluated functional statuses by having a neuropsychologist blinded to 
treatment groups perform frequent neuropsychological examinations.  Assessment was 
conducted on days 3, 7, 14, discharge and 3 and 6 months post-CA with the Pittsburg Outcome 
Scale.  This is a 5-category scale of cerebral performance categories (CPC). Levels include: CPC 
1: conscious and alert with normal cerebral function, CPC 2: conscious and alert with moderate 
cerebral function, CPC 3: conscious with severe cerebral disability, CPC 4: comatose or 
persistent vegetative state, and CPC 5: dead.  Data was dichotomized into good (CPC 1-2) and 
poor (CPC 3-5).  Additionally, cognitive function was assessed three and six months post CA by 
Q-EEG and event related P300 auditory evoked potential. 
RESULTS 
 The two randomized controlled trials and one cohort study selected for this review all had 
dichotomous data that was analyzed using "2 test, Confidence Intervals (CI), t-test, ANOVA and 
the Fisher exact test. 
Bernard et al reported functional status at hospital discharge via favorable and 
unfavorable outcomes.  Pre-hospital therapeutic hypothermia, paramedic cooling, was compared 
to induction upon hospital admission, hospital cooling; using 95% CI and the "2 test (Table 2). 
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At hospital discharge, 47.5% of the paramedic-cooled group and 52.6% of the hospital-cooled 
group had favorable outcomes. There was not a significant difference in favorable outcomes 
between groups (risk ratio 0.90, 95% CI 0.70 to 1.17, P=0.43), despite there being a significant 
difference in core body temperature upon arrival to the ED: paramedic cooled group 34.4 ± 1.2 
ºC, hospital cooled group 35.2 ± 1.0 ºC, P= 0.001, determined by t-test.  After 60 minutes, the 
difference core body temperature between groups was no longer statistically significant P=0.70. 
Table 2: Confidence Interval and P calculated by "2 test, reports outcomes at hospital discharge 
for paramedic and hospital cooling for the study performed by Bernard et al 2010. 
 Paramedic Cooling 
(n=118) 
Hospital Cooling 
(n=116) 
P* 
--Favorable outcome, n (%; 95% CI) 56 (47.5; 38.2–56.9) 61 (52.6; 43.1–61.9) 0.433 
Discharge to home, n (%; 95% CI) 24 (20.3; 13.5–28.7) 34 (29.3; 21.2–38.5) … 
Discharge to rehabilitation, n (%; 95%CI) 32 (27.1; 19.3–36.1) 27 (23.3; 15.9–32.0) … 
--Unfavorable outcome    
Discharge to nursing home awake, n 0 0 … 
Discharge to nursing home comatose, n (%; 95% 
CI) 
0 1 (0.9; 0.02–4.7) … 
  Dead, n (%; 95% CI) 62 (52.5; 43.1–61.8) 54 (46.6; 27.2–56.0) … 
 
When evaluating treatment effects, the relative benefit increase (RBI) was 11%, the 
absolute benefit increase (ABI) was 5%, and the number needed to treat (NNT) was 20 patients, 
which given this type of study is a large NNT.  The methods used may be considered safe and 
tolerable because no patients developed pulmonary edema or recurrent CA during hospital 
transport.  An interim analysis at 200 patients concluded there was no significant harm to study 
groups with a threshold of P<0.001.   
Kim et al evaluated patient survival status by comparing post-CA care with pre-hospital 
IV cooling to care without IV cooling.  Patients with an initial rhythm of VF allocated to pre-
hospital cooling showed improved survival rates and decreased mortality compared to patients 
allocated to normothermia (Table 3).  Kim et al reported these results were not statistically 
significant; however, no P-value was published. The outcome of ever awakening was also 
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evaluated.  It was found that 20/29 (69%) of patients allocated to cooling and 10/22 (45%) 
allocated to no cooling awakened (P=0.15, 2-sided Fisher exact test). Again, results 
demonstrated an increase in favorable outcomes with cooling, however the difference between 
groups was not statistically significant.4 
Table 3: Outcomes in Patients Resuscitated From OHCA and Randomized to Standard Care 
With or Without Field Cooling for the study performed by Kim et al 2007. 
Cooling (n=63), n (%) No Cooling (n=62), n (%)  
VF (n=29) No VF (n=34) VF (n=22) No VF (n=40) 
Deaths before hospital admission (in 
the field and emergency room) 
3 (10) 11 (32) 3 (14) 11 (27) 
In-hospital deaths 7 (24) 21 (62) 9 (41) 21 (52) 
Discharged alive 19 (66) 2 (6) 10 (45) 8 (20) 
 
To account for patients who had surface cooling initiated upon hospital admission, and 
that this treatment may modify the effect of pre-hospital cooling on survival to discharge status, 
an unadjusted odds ratio for field cooling was calculated, 1.25 (95% CI, 0.55 to 2.82).4  Kim et al 
reported this was an insignificant trend toward improved survival to hospital discharge.  In 
addition, a multiple logistics regression model revealed insignificant interaction between pre-
hospital cooling, hospital cooling, and interaction variables.  Lastly, the odds ratio was adjusted 
to account for effects of hospital cooling, and the ratio for survival to discharge increased slightly 
from 1.25 to 1.38 (95% CI, 0.58 to 3.29).4  
When evaluating treatment effects, RBI was 47%, the ABI was 21%, and the NNT was 5 
patients, a moderate NNT.  Tolerability and adverse effects of pre-hospital cooling were 
evaluated and significant findings are displayed in Table 4.  Despite significant elevations in 
heart rate and blood pressure being associated with pre-hospital cooling, the changes in pressure 
and heart rate from the time of randomization to ED arrival were similar. 
Table 4: Emergency Department and In-Hospital Safety Data From First 12 Hours, Values 
expressed as mean ± SD (n), compared with t-test. 
 Randomized to Field Not Randomized to P* 
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Cooling (n=56) Field Cooling (n=59) 
First heart rate on ED arrival, bpm 101±38 (56) 84±42 (58) 0.025 
First arterial blood gas pH 7.14±0.18 7.23±0.21 0.031 
Cardiomegaly on first CXR, n/N (%)   11/54 (20) 19/49 (39) 0.040 
 
Tiainen et al evaluated patient functional status using various neuropsychological 
examinations.  Pre-hospital therapeutic hypothermia was compared to standard normothermic 
post cardiac arrest care using CPC’s and the "2 test to compare proportions.  Table 5 reports 93% 
of therapeutic hypothermia patients compared to 78% of normothermia patients achieved good 
outcomes on the Pittsburg Outcomes Scale. And although not statistically significant, 67% 
hypothermic patients remained cognitively intact, some with mild impairment, compared to 44% 
of normothermic patients who achieved this same outcome.6 Both measures reveal an increase in 
functional status despite not being statistically significant.  
Table 5: Cerebral Performance Categories Three Months After CA in the study performed by 
Tiainen et al 2007. 
 Hypothermia (n=27) Normothermia (n=18) 
Good outcome; n (%) 25/27 (93) 14/18 (78) 
    -CPC1 19 10 
    -CPC2 6 4 
CPC3 2 4 
 
Q-EEG and P300 potentials were used to monitor brain activity and quantify cognitive 
impairment respectively. P300 potentials were gathered when patients were performing cognitive 
tasks. Patients with cognitive impairment were expected to have increased latency and decreased 
amplitude to the stimuli. Tiainen et al reported that patients in the hypothermia group had 
consistently more fast frequency and less slow frequency activity in all brain regions. Results 
between treatment groups were not statistically significant, however no P value was reported. 
Auditory Evoked P300 potentials are reported in Table 6.  Again, results trended toward 
increased cognitive function in hypothermic patients, which correlated to decreased latency and 
increased response amplitude.  Although response latency was not statistically significant 
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between treatments, P=0.453, response amplitudes were statistically significant, P=0.028. P300 
amplitudes were repeated 3 and 6 months following CA with CPC 3 patients, and again 
hypothermic patients had significantly higher amplitudes, P=0.016 and P=0.001 respectively.  
Table 6: Auditory Evoked P300 Potential, data given as mean and SD, compared with t-test. 
 Hypothermia (n=26) Normothermia (n=14) P Value 
Latency to P300 response, ms 374.4 (42.5) 385.6 (43.4) 0.453 
Amplitude of P300 response, µV 7.91 (5.12) 4.99 (2.99) 0.028 
 
Evaluation of treatment effects showed the RBI was 19%, the ABI was 15%, and the 
NNT was 7 patients, a moderate NNT.  Of the original 70 patients randomized to treatment, 50 
were alive at three months, 28/36 hypothermic patients and 22/34 normothermic patients, P= 
0.226.  Three additional patients were unconscious, one hypothermic and two normothermic 
group patients. No other adverse events or safety concerns were reported. 
Bernard et al excluded patients who were not intubated, were dependent on others for 
ADL’s prior to the OHCA, obviously pregnant, or already hypothermic.  Only patients with an 
initial rhythm of VF were included, compared to Kim et al who included patients with asystole 
and PEA, and Tiainen et al who included patients with a non-perfusing tachycardia. Of the 118 
patients Bernard allocated to pre-hospital cooling, 48% received the full 2 L of ice-cold LR, and 
8 patients receive no ice-cold fluids.  The other 43% of patients, received between 0.5-2 L of ice-
cold LR. Of the 116 patients allocated to hospital cooling, one received 2L of ice-cold LR.  Kim 
et al had poorer compliance with study protocol.  Only 19% of patients received the full 2 L, of 4 
ºC NS, and 45% of patients received between 0.5-2 L. Again 8 patients allocated to this 
treatment received no saline. Tiainen et al did not comment on protocol compliance. 
DISCUSSION 
 Less than 50% of patients whose circulation returns survive to hospital discharge, and of 
those who do survive, the main cause of death within one month of CA is anoxic brain injury.5 
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Early interventions like therapeutic hypothermia that reduce cell death, reactive oxygen species, 
and post-ischemic inflammation state may help improve post-CA functional and survival status.   
The study performed by Bernard et al compared the time of initiation of therapeutic 
hypothermia and its effects. It revealed that patients who began cooling upon hospital admission 
had an increased rate of favorable outcomes, but that results were not statistically significant 
compared to patients who were cooled prior to hospital arrival. The study was limited by failure 
to infuse the full 2 L of ice-cold LR to more than 50% of patients due to short hospital transport 
time1. Additionally, the modest decrease in core body temperature prior to hospital arrival, 0.8 
ºC, was for a very brief duration.1 Other limiting factors include paramedics and emergency 
personal were not blinded to the treatment groups, tympanic temperature, an inferior method 
core body temperature determination was used by paramedics, the study was terminated prior to 
reaching sample size, and no long-term measurements of neurological outcome were assessed1.  
Kim et al and Tiainen et al both compared the experimental condition, therapeutic 
hypothermia, to the gold standard treatment, normothermic post-CA care.  All results favored 
increased survival and functional status for patients randomized to therapeutic hypothermia, 
however all results excluding the hypothermia patients’ increased P300 amplitude responses 
reported by Tiainen et al were statistically not statistically significant.  
Kim et al experienced similar limitations as Bernard et al in reference to short transport 
time reducing the volume of 4 ºC NS infused therefore minimizing the reduction in core body 
temperature.  Again, paramedics and hospital staff were not blinded to treatment.  Additionally, 
there was poor compliance at some institutions in assessing follow-up temperatures and hospital 
cooling of patients. To maintain a control between treatments, normothermia patients should 
have received the same volume of room temperature IVF as cooled patients received 4 ºC NS. 
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This was not accounted for.  Most importantly, both Kim and Tiainen et al concluded that the 
sample size for each study was not sufficient to determine conclusive results on the effects of 
therapeutic hypothermia on patient outcomes.  While this review mainly addressed patients with 
an initial rhythm of VF, Kim et al also evaluated patients in PEA and asystole.  In this study, 
patients whose initial rhythm was not VF had increased favorable outcomes when randomized to 
normothermia.  This trend was opposite of that for patients with an initial rhythm of VF.  
Therapeutic hypothermia is now becoming part of the standard treatment for post-CA 
patients in the United States. Pioneered by larger universities, this treatment is now being 
incorporated into smaller community hospitals’ post-CA protocol. All studies used in this review 
reported that their techniques were safe and not associated with cognitive or functional deficits. 
CONCLUSION 
The studies reviewed display inconclusive evidence that pre-hospital therapeutic 
hypothermia improves functional or survival status of patients following CA. Kim and Tiainen et 
al demonstrated an increased occurrence of favorable outcomes for patients with initial VF 
randomized to pre-hospital therapeutic hypothermia. Studies with adequate sample sizes and 
improved compliance are needed to determine if this treatment significantly improves outcomes.  
More recent laboratory data suggests that induction of therapeutic hypothermia during 
CPR increases the rate of successful defibrillation and contributes to earlier cerebral cooling.1 
Future studies may alter methods to initiate cooling with more rapid infusion (>100mL/min) of 
large volume (40mL/kg) intravenous crystalloid fluid.1 Initial studies report that these methods 
don’t contribute to pulmonary edema, but their safety in terms of coaguability effects must be 
determined. Combining these new methods, it may be determined if pre-hospital therapeutic 
hypothermia significantly improves functional and survival status of cardiac arrest patients.
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